Integrated Filing — IndAS

General information about company
Scrip Code	540203
NSE Symbol	SFL
MSEI Symbol	NOTLISTED
ISIN	INE916U01025
Name of company	Sheela Foam Limited
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	14-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	09-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	PU-FOAM
Start date and time of board meeting	14-May-2025   14:30:00
End date and time of board meeting	14-May-2025   19:15:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	No
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2024-05-21
Indicate Company website link for updated RPT policy of the Company	https://backend.sheelafoam.com/wp-content/uploads/2025/03/related-party-transaction-policy.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
Company has not made any default in repayment of interest or principle of loan

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	6905900000	25875100000
	Other income	200800000	831400000
	Total income	7106700000	26706500000
2	Expenses
(a)	Cost of materials consumed	3436000000	13754400000
(b)	Purchases of stock-in-trade	998700000	3360400000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	159000000	-395000000
(d)	Employee benefit expense	559500000	2219900000
(e)	Finance costs	284600000	944500000
(f)	Depreciation, depletion and amortisation expense	242100000	886500000
(f)	Other Expenses
1	Other Manufacturing Expenses	189000000	725200000
2	Other Expenses	1107100000	3859400000
	Total other expenses	1296100000	4584600000
	Total expenses	6976000000	25355300000
3	Total profit before exceptional items and tax	130700000	1351200000
4	Exceptional items	0	119100000
5	Total profit before tax	130700000	1470300000
6	Tax expense
7	Current tax	47300000	453900000
8	Deferred tax	-38400000	-104500000
9	Total tax expenses	8900000	349400000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	121800000	1120900000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	121800000	1120900000
17	Other comprehensive income net of taxes	7300000	-700000
18	Total Comprehensive Income for the period	129100000	1120200000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	543500000	543500000
	Face value of equity share capital	5	5
27	Details of debt securities
22	Reserves excluding revaluation reserve		0
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	1.12	10.31
	Diluted earnings (loss) per share from continuing operations	1.12	10.29
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	1.12	10.31
	Diluted earnings (loss) per share from continuing and discontinued operations	1.12	10.29
24	Debt equity ratio	0.0034	0.0034
25	Debt service coverage ratio	0.0012	0.0052
26	Interest service coverage ratio	0.0146	0.0243
27	Disclosure of notes on financial results

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	5581100000
	Capital work-in-progress	393600000
	Investment property	28100000
	Goodwill	0
	Other intangible assets	0
	Intangible assets under development	0
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	26477600000
	Trade receivables, non-current	0
	Loans, non-current	796700000
	Other non-current financial assets	414200000
	Total non-current financial assets	27688500000
	Deferred tax assets (net)	165600000
	Other non-current assets	52300000
	Total non-current assets	33909200000
2	Current assets
	Inventories	1972900000
	Current financial asset
	Current investments	4645200000
	Trade receivables, current	2391400000
	Cash and cash equivalents	226400000
	Bank balance other than cash and cash equivalents	3100000
	Loans, current	10400000
	Other current financial assets	149900000
	Total current financial assets	7426400000
	Current tax assets (net)	0
	Other current assets	575300000
	Total current assets	9974600000
3	Non-current assets classified as held for sale	12700000
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	43896500000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	543500000
	Other equity	27393800000
	Total equity attributable to owners of parent	27937300000
	Non controlling interest
	Total equity	27937300000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	4354400000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	188500000
	Total non-current financial liabilities	4542900000
	Provisions, non-current	132000000
	Deferred tax liabilities (net)	12500000
	Deferred government grants, Non-current	0
	Other non-current liabilities	335200000
	Total non-current liabilities	5022600000
	Current liabilities
	Current financial liabilities
	Borrowings, current	5132300000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	266600000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	1987800000
	Total Trade payable	2254400000
	Other current financial liabilities	2200600000
	Total current financial liabilities	9587300000
	Other current liabilities	1012500000
	Provisions, current	127300000
	Current tax liabilities (Net)	209500000
	Deferred government grants, Current	0
	Total current liabilities	10936600000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	15959200000
	Total equity and liabilites	43896500000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Remeasurement gain/ (loss) of net defined benefit plans	8400000	-6500000
	Total Amount of items that will not be reclassified to profit and loss	8400000	-6500000
2	Income tax relating to items that will not be reclassified to profit or loss	2200000	-1600000
3	Amount of items that will be reclassified to profit and loss
1	Fair value gain/ (loss) on investments and other financial instruments	1400000	5600000
	Total Amount of items that will be reclassified to profit and loss	1400000	5600000
4	Income tax relating to items that will be reclassified to profit or loss	300000	1400000
5	Total Other comprehensive income	7300000	-700000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			1470300000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			944500000
	Adjustments for decrease (increase) in inventories			-391200000
	Adjustments for decrease (increase) in trade receivables, current			-512600000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			-32600000
	Adjustments for decrease (increase) in other non-current assets			-326100000
	Adjustments for other financial assets, non-current			45400000
	Adjustments for other financial assets, current			-68500000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			643500000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			396700000
	Adjustments for increase (decrease) in other non-current liabilities			333500000
	Adjustments for depreciation and amortisation expense			886500000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			15600000
	Adjustments for provisions, non-current			-120300000
	Adjustments for other financial liabilities, current			-389300000
	Adjustments for other financial liabilities, non-current			31100000
	Adjustments for unrealised foreign exchange losses gains			30900000
	Adjustments for dividend income			0
	Adjustments for interest income			118800000
	Adjustments for share-based payments			74200000
	Adjustments for fair value losses (gains)			-141400000
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			-26100000
	Other adjustments to reconcile profit (loss)			-119100000
	Other adjustments for non-cash items			-331000000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			824900000
	Net cash flows from (used in) operations			2295200000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			18400000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			2276800000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			383700000
	Other cash receipts from sales of equity or debt instruments of other entities			1009500000
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			509400000
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			78100000
	Purchase of property, plant and equipment			862200000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			28600000
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			146400000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			24500000
	Net cash flows from (used in) investing activities	-525400000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			0
	Repayments of borrowings			1253800000
	Payments of lease liabilities			138900000
	Dividends paid			0
	Interest paid			258400000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			-1651100000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			100300000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			100300000
	Cash and cash equivalents cash flow statement at beginning of period			126100000
	Cash and cash equivalents cash flow statement at end of period			226400000